3,5-diiodothyropropionic acid and Benign Neoplasms

3,5-diiodothyropropionic acid has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Actis, M; Evison, B; Fujii, N; Inoue, A; Perry, S; Punchihewa, C	1

Other Studies

1 other study(ies) available for 3,5-diiodothyropropionic acid and Benign Neoplasms

Article	Year
Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis. Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7 Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DNA Damage; DNA Replication; HeLa Cells; Humans; Neoplasms; Proliferating Cell Nuclear Antigen; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship	2013

Article

Year

Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.

Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DNA Damage; DNA Replication; HeLa Cells; Humans; Neoplasms; Proliferating Cell Nuclear Antigen; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship

2013